Loading the company…
Loading the company…
Families: Peripheral nerve stimulation & intrathecal pumps.
All companies · Product and company coverage
In 2025, Intera Oncology reported engagement with 258 surgeons and other clinicians in the states MedaRep covers, worth $92K in consulting, speaking, meals and travel for its device products, the most in Pennsylvania ($21K to 14). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Pennsylvania ($21K, 14 engaged), Tennessee ($17K, 17 engaged), New York ($15K, 23 engaged), Missouri ($7,963, 11 engaged), Texas ($5,490, 21 engaged).
In the last ten years FDA made 29 decisions for Intera Oncology (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2024 (5). The latest was on 2026-03-16.
| Family | Decisions on record |
|---|---|
| Peripheral nerve stimulation & intrathecal pumps | 119 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-03-16 | PMA | P890055-S093 | MEDSTREAM PROGRAMMABLE INFUSION PUMP SYSTEM · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-02-26 | PMA | P890055-S092 | lntera 3000 Hepatic Artery Infusion Pump · Labeling Change - Indications/instructions/shelf life/tradename |
| 2025-05-09 | PMA | P890055-S089 | Intera 3000 Hepatic Artery Infusion Pump · Labeling Change - Indications/instructions/shelf life/tradename |
| 2025-05-07 | PMA | P890055-S090 |
| Intera 3000 Hepatic Arterial Infusion Pump · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2024-10-30 | PMA | P890055-S088 | MEDSTREAM PROGRAMMABLE INFUSION PUMP SYSTEM · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Intera Oncology.